HuGE Literature Finder
Records
1
-
7
Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study. Pharmacogenetics and genomics 2021 Nov . Eliasen Astrid, Kornholt Jonatan, Mathiasen René, Wadt Karin, Stoltze Ulrik, Brok Jesper, Rechnitzer Catherine, Schmiegelow Kjeld, Dalhoff K |
Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients. Asia-Pacific journal of clinical oncology 2017 Feb 13 (1): 53-60. Kang Gaeun, Kim Ka-Rham, Shim Hyun-Jeong, Hwang Jun-Eul, Bae Woo-Kyun, Chung Ik-Joo, Kim Hee-Nam, Lee Jongtae, Choi Kyungmee, Shin Hee-Young, Kim Jong-Keun, Jeong Seong-Wook, Cho Sang-H |
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? BMJ open 2015 5 (5): e006818. Currow David C, Quinn Stephen, Ekstrom Magnus, Kaasa Stein, Johnson Miriam J, Somogyi Andrew A, Klepstad P |
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. European journal of cancer (Oxford, England : 1990) 2011 Jul 47 (11): 1682-91. Laugsand Eivor A, Fladvad Torill, Skorpen Frank, Maltoni Marco, Kaasa Stein, Fayers Peter, Klepstad P |
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 2011 May 152 (5): 1139-45. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers P M, Kaasa S, , |
Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. Pharmacogenomics 2010 Jul 11 (7): 943-50. Hammer Christian, Fasching Peter A, Loehberg Christian R, Rauh Claudia, Ekici Arif B, Jud Sebastian M, Bani Mayada R, Beckmann Matthias W, Strick Reiner, Niesler Bea |
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. Journal of cancer research and clinical oncology 2008 Oct 134 (10): 1079-86. Fasching P A, Kollmannsberger B, Strissel P L, Niesler B, Engel J, Kreis H, Lux M P, Weihbrecht S, Lausen B, Bani M R, Beckmann M W, Strick |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: